HCM

HUTCHMED (China) Ltd HCM

NasdaqLarge CapHealthcare
InternationalScored off the official board: an annual-only filer, so this data lags a domestic quarterly filer.

13F Pro quality score

Rank #2,700 of 2,925

Why it scores 23Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$548.51M

Quarter to Dec 31

Net income

$456.91M

Quarter to Dec 31

Free cash flow

$-78.81M

Quarter to Dec 31

Operating margin

-7.1%

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$51.82M total
SCHRODER INVESTMENT MANAGEMENT GROUP
$15.82M0.0%
Allianz Asset Management GmbH
$12.53M0.0%
STATE STREET CORP
$3.37M+2.9%
AIA Group Ltd
$3.13M0.0%
M&G Plc
$2.67M-5.0%
Amundi
$2.20M-12.0%
JANE STREET GROUP, LLC
$2.09M+154.2%
RENAISSANCE TECHNOLOGIES LLC
$1.40M-1.4%
BNP PARIBAS FINANCIAL MARKETS
$1.12M-2.0%
XY Capital Ltd
$1.12M+115.2%
Crossmark Global Holdings, Inc.
$913.7K-0.1%
ACADIAN ASSET MANAGEMENT LLC
$696.0KNew
TWO SIGMA INVESTMENTS, LP
$680.5KNew
UBS Group AG
$475.4K-1.3%
Vanguard Personalized Indexing Management, LLC
$458.4K+108.6%
DIMENSIONAL FUND ADVISORS LP
$419.3K-30.4%
CITADEL ADVISORS LLC
$409.5K+24.7%
Vident Advisory, LLC
$286.0K+50.0%
MILLENNIUM MANAGEMENT LLC
$284.3K-5.7%
StoneX Group Inc.
$213.6KNew
GEODE CAPITAL MANAGEMENT, LLC
$195.5K-16.8%
Janney Montgomery Scott LLC
$186.0K-29.1%
AMERIPRISE FINANCIAL INC
$169.4K+5.2%
Summit Trail Advisors, LLC
$140.8K0.0%
BANK OF AMERICA CORP /DE/
$134.4K0.0%
See all 56 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Operating Margin

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Debt/Equity

FY 2025
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/HCM

Loading ratio trend…

HCM key financials by period

Reported revenue, net income and operating margin by fiscal year, from HUTCHMED (China) Ltd's annual filings on SEC EDGAR.

HUTCHMED (China) Ltd reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$548.5M$456.9M-7.1%
FY 2024$630.2M$37.7M-6.9%
FY 2023$838.0M$100.8M2.2%
FY 2022$426.4M$-360.8M-95.6%
FY 2021$356.1M$-194.6M-92.2%
FY 2020$228.0M$-125.7M-86.3%
Source: HCM filings on SEC EDGAR →

Companies similar to HCM

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

HCM insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About HUTCHMED (China) Ltd (HCM): stock profile, AI score and financials

HUTCHMED (China) Ltd (HCM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores HCM at 22.9/100 on a composite quality score built from its SEC filings, placing it at rank #2,700 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), HUTCHMED (China) Ltd reports quarterly revenue of $548.5M, net income of $456.9M, an operating margin of -7.1%. Top institutional holders of HCM by reported 13-F value include SCHRODER INVESTMENT MANAGEMENT GROUP, Allianz Asset Management GmbH, STATE STREET, based on the most recent SEC filings. HCM trades on the Nasdaq exchange and files with the SEC under CIK 1648257. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HCM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HUTCHMED (China) Ltd directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1648257 →